Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
European Journal of Clinical Pharmacology
|
September 17, 2009
Eltrombopag, an oral thrombopoietin receptor agonist, has no impact on the pharmacokinetic profile of probe drugs for cytochrome P450 isoenzymes CYP3A4, CYP1A2, CYP2C9 and CYP2C19 in healthy men: a cocktail analysis
Julian Jenkins, Daphne Williams, Yanli Deng, et al.
Human Fertility (Cambridge, England)
|
May 28, 2017
Bemfola<sup>®</sup> fixed dose pens potentially reduce drug wastage and associated costs of infertility treatment
Graham Foxon, Paul Mitchell, Nikki Turner, et al.
Seminars in Reproductive Medicine
|
October 8, 2024
Patient-Centric In Vitro Fertilization Prognostic Counseling Using Machine Learning for the Pragmatist
Mylene W M Yao, Julian Jenkins, Elizabeth T Nguyen, et al.
Brain Topography
|
March 8, 2011
The elicitation of audiovisual steady-state responses: multi-sensory signal congruity and phase effects
Julian Jenkins, Ariane E Rhone, William J Idsardi, et al.
Journal of Gynecology Obstetrics and Human Reproduction
|
November 20, 2022
A real-world study of ART in France (REOLA) comparing a biosimilar rFSH against the originator according to rFSH starting dose
Paul Barrière, Samir Hamamah, Elisangela Arbo, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology: X
|
September 2, 2024
Reply to Letter to Editor from Juan-Enrique Schwarze and colleagues - Critical appraisal on "Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France"
Matthieu Lehmann, Jean-Luc Pouly, Paul Barrière, et al.
Fertility Research and Practice
|
August 4, 2020
The continuum of ovarian response leading to BIRTH, a real world study of ART in Spain
Marcos Ferrando, Buenaventura Coroleu, Luis Rodríguez-Tabernero, et al.
Fertility and Sterility
|
July 9, 2004
Epidermal growth factor contamination and concentrations of intact human chorionic gonadotropin in commercial preparations
Sarah J Yarram, Julian Jenkins, Lawrence A Cole, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology: X
|
May 14, 2024
Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France
Matthieu Lehmann, Elisangela Arbo, Jean-Luc Pouly, et al.
Journal of Clinical Pharmacology
|
April 27, 2010
Clinical pharmacokinetics, platelet response, and safety of eltrombopag at supratherapeutic doses of up to 200 mg once daily in healthy volunteers
Gemma Matthys, Jung Wook Park, Sandra McGuire, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
European Journal of Clinical Pharmacology
|
September 17, 2009
Eltrombopag, an oral thrombopoietin receptor agonist, has no impact on the pharmacokinetic profile of probe drugs for cytochrome P450 isoenzymes CYP3A4, CYP1A2, CYP2C9 and CYP2C19 in healthy men: a cocktail analysis
Julian Jenkins, Daphne Williams, Yanli Deng, et al.
Human Fertility (Cambridge, England)
|
May 28, 2017
Bemfola<sup>®</sup> fixed dose pens potentially reduce drug wastage and associated costs of infertility treatment
Graham Foxon, Paul Mitchell, Nikki Turner, et al.
Seminars in Reproductive Medicine
|
October 8, 2024
Patient-Centric In Vitro Fertilization Prognostic Counseling Using Machine Learning for the Pragmatist
Mylene W M Yao, Julian Jenkins, Elizabeth T Nguyen, et al.
Brain Topography
|
March 8, 2011
The elicitation of audiovisual steady-state responses: multi-sensory signal congruity and phase effects
Julian Jenkins, Ariane E Rhone, William J Idsardi, et al.
Journal of Gynecology Obstetrics and Human Reproduction
|
November 20, 2022
A real-world study of ART in France (REOLA) comparing a biosimilar rFSH against the originator according to rFSH starting dose
Paul Barrière, Samir Hamamah, Elisangela Arbo, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology: X
|
September 2, 2024
Reply to Letter to Editor from Juan-Enrique Schwarze and colleagues - Critical appraisal on "Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France"
Matthieu Lehmann, Jean-Luc Pouly, Paul Barrière, et al.
Fertility Research and Practice
|
August 4, 2020
The continuum of ovarian response leading to BIRTH, a real world study of ART in Spain
Marcos Ferrando, Buenaventura Coroleu, Luis Rodríguez-Tabernero, et al.
Fertility and Sterility
|
July 9, 2004
Epidermal growth factor contamination and concentrations of intact human chorionic gonadotropin in commercial preparations
Sarah J Yarram, Julian Jenkins, Lawrence A Cole, et al.
European Journal of Obstetrics & Gynecology and Reproductive Biology: X
|
May 14, 2024
Determining the cost-effectiveness of follitropin alfa biosimilar compared to follitropin alfa originator in women undergoing fertility treatment in France
Matthieu Lehmann, Elisangela Arbo, Jean-Luc Pouly, et al.
Journal of Clinical Pharmacology
|
April 27, 2010
Clinical pharmacokinetics, platelet response, and safety of eltrombopag at supratherapeutic doses of up to 200 mg once daily in healthy volunteers
Gemma Matthys, Jung Wook Park, Sandra McGuire, et al.
Page
of 3